Literature DB >> 33584254

What Is the Difference Between Observed Association and Causal Association, Signals and Evidence? Examples Related to COVID-19.

Vicki Osborne1,2, Saad A W Shakir1,2.   

Abstract

Entities:  

Keywords:  COVID-19; association; causation; evidence; signal

Year:  2021        PMID: 33584254      PMCID: PMC7879446          DOI: 10.3389/fphar.2020.569189

Source DB:  PubMed          Journal:  Front Pharmacol        ISSN: 1663-9812            Impact factor:   5.810


× No keyword cloud information.
  14 in total

1.  The environment and disease: association or causation? 1965.

Authors:  Austin Bradford Hill
Journal:  J R Soc Med       Date:  2015-01       Impact factor: 5.344

2.  Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.

Authors:  Khai Li Chai; Sarah J Valk; Vanessa Piechotta; Catherine Kimber; Ina Monsef; Carolyn Doree; Erica M Wood; Abigail A Lamikanra; David J Roberts; Zoe McQuilten; Cynthia So-Osman; Lise J Estcourt; Nicole Skoetz
Journal:  Cochrane Database Syst Rev       Date:  2020-10-12

3.  Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma.

Authors:  Chenguang Shen; Zhaoqin Wang; Fang Zhao; Yang Yang; Jinxiu Li; Jing Yuan; Fuxiang Wang; Delin Li; Minghui Yang; Li Xing; Jinli Wei; Haixia Xiao; Yan Yang; Jiuxin Qu; Ling Qing; Li Chen; Zhixiang Xu; Ling Peng; Yanjie Li; Haixia Zheng; Feng Chen; Kun Huang; Yujing Jiang; Dongjing Liu; Zheng Zhang; Yingxia Liu; Lei Liu
Journal:  JAMA       Date:  2020-04-28       Impact factor: 56.272

4.  Applying the Bradford Hill criteria in the 21st century: how data integration has changed causal inference in molecular epidemiology.

Authors:  Kristen M Fedak; Autumn Bernal; Zachary A Capshaw; Sherilyn Gross
Journal:  Emerg Themes Epidemiol       Date:  2015-09-30

5.  More evidence is urgently needed to confirm the relation between angiotensin-converting enzyme inhibitors and COVID-19.

Authors:  Shengju Yang; Guoliang Meng
Journal:  J Mol Cell Cardiol       Date:  2020-04-06       Impact factor: 5.000

6.  Effectiveness of convalescent plasma therapy in severe COVID-19 patients.

Authors:  Kai Duan; Bende Liu; Cesheng Li; Huajun Zhang; Ting Yu; Jieming Qu; Min Zhou; Li Chen; Shengli Meng; Yong Hu; Cheng Peng; Mingchao Yuan; Jinyan Huang; Zejun Wang; Jianhong Yu; Xiaoxiao Gao; Dan Wang; Xiaoqi Yu; Li Li; Jiayou Zhang; Xiao Wu; Bei Li; Yanping Xu; Wei Chen; Yan Peng; Yeqin Hu; Lianzhen Lin; Xuefei Liu; Shihe Huang; Zhijun Zhou; Lianghao Zhang; Yue Wang; Zhi Zhang; Kun Deng; Zhiwu Xia; Qin Gong; Wei Zhang; Xiaobei Zheng; Ying Liu; Huichuan Yang; Dongbo Zhou; Ding Yu; Jifeng Hou; Zhengli Shi; Saijuan Chen; Zhu Chen; Xinxin Zhang; Xiaoming Yang
Journal:  Proc Natl Acad Sci U S A       Date:  2020-04-06       Impact factor: 11.205

7.  A real-time dashboard of clinical trials for COVID-19.

Authors:  Kristian Thorlund; Louis Dron; Jay Park; Grace Hsu; Jamie I Forrest; Edward J Mills
Journal:  Lancet Digit Health       Date:  2020-04-24

8.  First Case of 2019 Novel Coronavirus in the United States.

Authors:  Michelle L Holshue; Chas DeBolt; Scott Lindquist; Kathy H Lofy; John Wiesman; Hollianne Bruce; Christopher Spitters; Keith Ericson; Sara Wilkerson; Ahmet Tural; George Diaz; Amanda Cohn; LeAnne Fox; Anita Patel; Susan I Gerber; Lindsay Kim; Suxiang Tong; Xiaoyan Lu; Steve Lindstrom; Mark A Pallansch; William C Weldon; Holly M Biggs; Timothy M Uyeki; Satish K Pillai
Journal:  N Engl J Med       Date:  2020-01-31       Impact factor: 91.245

9.  Tocilizumab, an anti-IL-6 receptor antibody, to treat COVID-19-related respiratory failure: a case report.

Authors:  J-M Michot; L Albiges; N Chaput; V Saada; F Pommeret; F Griscelli; C Balleyguier; B Besse; A Marabelle; F Netzer; M Merad; C Robert; F Barlesi; B Gachot; A Stoclin
Journal:  Ann Oncol       Date:  2020-04-02       Impact factor: 32.976

10.  Convalescent plasma as a potential therapy for COVID-19.

Authors:  Long Chen; Jing Xiong; Lei Bao; Yuan Shi
Journal:  Lancet Infect Dis       Date:  2020-02-27       Impact factor: 25.071

View more
  1 in total

1.  An Overview of COVID-19 Vaccine Safety and Post-marketing Surveillance Systems.

Authors:  Manal Mohammed Younus; Ali Azeez Al-Jumaili
Journal:  Innov Pharm       Date:  2021-09-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.